European Cancer Market Outlook

European Cancer Market Outlook

 

RELEASE DATE
24-Jun-2011
REGION
Europe
Research Code: M62A-01-00-00-00
SKU: HC01896-EU-MR_06931
AvailableYesPDF Download

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC01896-EU-MR_06931

$4,950.00

$3,712.50save 25 %

DownloadLink
ENQUIRE NOW

Description

This research service analyses the European cancer drugs therapeutics market. The base year is 2010 with forecasts running through 2017. It analyses market drivers, restraints and challenges faced by industry participants. Total revenue forecasts of the cancer drugs market in Europe and pipeline analysis have been discussed. An overview of key cancer indications and treatment options are also provided. Moreover, it provides strategic recommendations for market players. Furthermore, it provides decision support databases which is a collection of multiple tables that cover a sector's demand, supply, select customer demographics and pertinent economic measurements.

Table of Contents

Summary of the European Cancer Markets

  • Executive Summary of the European Cancer Markets

Introduction

  • Scope and Segmentation
  • Assumptions and Limitations
  • Glossary of Terms and Abbreviations
  • Epidemiology
  • Cancer Treatment Pathways

Market Trends and Dynamics

  • Market Overview
  • Key Trends in Cancer Therapeutics
  • Key Trends in Cancer Diagnostics
  • Market Engineering Measurements
  • Industry Challenges
  • Market Drivers
  • Market Restraints
  • Revenue Forecasts

Major Cancer Types and Treatment Options

Current Therapeutic Options

  • Cancer Indications - Overview
  • Lung Cancer
  • Colorectal Cancer
  • Breast Cancer
  • Ovarian Cancer
  • Prostate Cancer
  • Pancreatic Cancer
  • Hodgkin's Disease (HD) and Non-Hodgkin's Lymphoma (NHL)
  • Head and Neck Cancer
Related Research
This research service analyses the European cancer drugs therapeutics market. The base year is 2010 with forecasts running through 2017. It analyses market drivers, restraints and challenges faced by industry participants. Total revenue forecasts of the cancer drugs market in Europe and pipeline analysis have been discussed. An overview of key cancer indications and treatment options are also provided. Moreover, it provides strategic recommendations for market players. Furthermore, it provides decision support databases which is a collection of multiple tables that cover a sector's demand, supply, select customer demographics and pertinent economic measurements.
More Information
No Index Yes
Podcast No
Industries Healthcare
WIP Number M62A-01-00-00-00
Is Prebook No